EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

ICES13, autologous myoblasts for stress urinary incontinence

ICES13 are autologous myoblasts collected from the upper arm. Transurethral ultrasound-directed injection of ICES13, in combination with functional electrical stimulation, is used to treat patients with intrinsic urinary sphincter deficiency. Treatment was found to be safe and improved the condition according to measurements with the functional electrical stimulation.

Clinical trial 2009-016597-32 phase 3. Clinical trial 2010-021871-10 phase 2 and 3. Clinical trial 2009-011797-15 phase 2. Clinical trial 2010-021867-34 phase 1
See additional Cell Therapies for: Lower Urinary Tract
ICES13, autologous myoblasts for stress urinary incontinence